Aerovate Therapeutics Inc

NASDAQ:AVTE   11:25:42 AM EDT
11.16
-0.20 (-1.76%)
Earnings Announcements

Aerovate Therapeutics Announces Third Quarter 2021 Financial Results

Published: 11/15/2021 13:34 GMT
Aerovate Therapeutics Inc (AVTE) - Aerovate Therapeutics Announces Third Quarter 2021 Financial Results.
Aerovate Therapeutics Inc- Qtrly Loss per Share $0.26.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.32

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.